CV Sciences (CVSI) Long-Term Deferred Tax (2022 - 2025)
CV Sciences (CVSI) reported Long-Term Deferred Tax of $13.5 million for Q4 2025, down 1.28% on a YoY basis from $13.7 million in Q4 2024, and down 1.28% sequentially from $13.7 million in Q4 2024.
CV Sciences (CVSI) Long-Term Deferred Tax (2022 - 2025) Analysis & Trends
CV Sciences (CVSI) has 4 years of Long-Term Deferred Tax data on file, last reported at $13.5 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Deferred Tax fell 1.28% year-over-year to $13.5 million; the trailing twelve-month figure through Dec 2025 stood at $13.5 million (down 1.28% YoY), and the FY2025 full-year result was $13.5 million, down 1.28% from the prior year.
- Long-Term Deferred Tax eased to $13.5 million in Q4 2025, from $13.7 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $17.9 million in Q4 2022 to a low of $13.5 million in Q4 2025.
- A 4-year average of $15.6 million and a median of $15.4 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax slipped 20.28% in 2024 and decreased 1.28% in 2025, its largest moves.
- Tracing CVSI's Long-Term Deferred Tax over 4 years: stood at $17.9 million in 2022, then decreased by 4.28% to $17.1 million in 2023, then fell by 20.28% to $13.7 million in 2024, then dropped by 1.28% to $13.5 million in 2025.
- Business Quant data shows CVSI's Long-Term Deferred Tax at $13.5 million in Q4 2025, $13.7 million in Q4 2024, and $17.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.49 Mn |
| Dec 31, 2024 | 13.67 Mn |
| Dec 31, 2023 | 17.15 Mn |
| Dec 31, 2022 | 17.91 Mn |